Clinical Trial Update: ONO-4578-06:Phase I Study of ONO-4578 and Letrozole Plus CDK4 /6 Inhibitors in Breast Cancer [Phase 1]

View source ↗

Summary

Phase I study of ONO-4578 with letrozole and CDK4/6 inhibitors for breast cancer is currently active but not recruiting; no results are reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CDK4/6 inhibitors
• Letrozole (letrozole)
• ONO-4578

Snippet

Sponsor: Ono Pharmaceutical Co., Ltd. | Conditions: Hormone Receptor-positive Breast Cancer, HER2-negative Breast Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING